Pulmonary fibrosis (PF) is a chronic and ultimately fatal interstitial lung disease of various
causes. The advent of nintedanib and pirfenidone provides treatment options for PF patients …

Context Baicalin, a major flavonoid extracted from Scutellaria baicalensis Georgi
(Lamiaceae), has been shown to exert therapeutic effects on pulmonary fibrosis (PF) …

This article reviews the most important articles published in interstitial lung disease, as
reviewed during the Clinical Year in Review session at the 2012 annual European …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus
disease 2019 (COVID-19) has been a global health concern since 2019. The viral spike …

Fibrosis is the final common pathology of most chronic diseases as seen in the heart, liver,
lung, kidney, and skin and contributes to nearly half of death in the developed countries …

Pulmonary fibrosis is a severe and progressive disease that is characterized by an abnormal
deposition of extracellular matrix, such as collagens. The pathogenesis of this disease may …

Backgrounds Pulmonary fibrosis (PF) is a pathological state presenting at the progressive
stage of heterogeneous interstitial lung disease (ILD). The current understanding of the …

Pulmonary fibrosis (PF) is a severe chronic lung disease with little effective treatment options
other than lung transplantation. Adipose‐derived mesenchymal stem cells (ADSCs) have …

Polyhexamethylene guanidine phosphate (PHMG-p) is an active ingredient of humidifier
disinfectants and causes severe lung injury resulting in pulmonary fibrosis. Current evidence …

Fibroblast–myofibroblast differentiation (FMD) is a critical cellular phenotype during the
occurrence and deterioration of pulmonary fibrosis (PF). FMD can increase with an elevated …